Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Middle East Pharmaceutical Industries Co Quick Ratio?
Middle East Pharmaceutical Industries CoSAU:4016 +0.92%22 Quick Ratio is 2.18 as of Mar. 2026, which is 6% above its 10-year median of 2.06. GuruFocus rates SAU:4016 with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 997 Drug Manufacturers companies, Middle East Pharmaceutical Industries Co ranks better than 66.3% on this metric.
SAU:4016's Quick Ratio is ranked better than 66.3% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs SAU:4016: 2.18
Middle East Pharmaceutical Industries Co (SAU:4016) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Middle East Pharmaceutical Industries Co Quick Ratio Related Terms
Middle East Pharmaceutical Industries Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Pharmaceutical Industries Co Quick Ratio Chart
Middle East Pharmaceutical Industries Co Annual Data
Trend
Dec23
Dec24
Dec25
Quick Ratio
1.64
1.95
2.35
Middle East Pharmaceutical Industries Co Quarterly Data
SAU:4016 vs ZTS, UTHR, VTRS: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Middle East Pharmaceutical Industries Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Pharmaceutical Industries Co Quick Ratio vs Drug Manufacturers Industry
Middle East Pharmaceutical Industries Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Middle East Pharmaceutical Industries Co (SAU:4016) has a Quick Ratio of 2.18 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Middle East Pharmaceutical Industries Co and its competitors. This is near median its historical median of 2.06. Over the past decade, Middle East Pharmaceutical Industries Co's Quick Ratio has ranged from 1.43 to 2.74. According to the industry distribution chart, Middle East Pharmaceutical Industries Co ranks #336 out of 997 companies in the Drug Manufacturers industry, placing it in the top 33.7%.
Is Middle East Pharmaceutical Industries Co's Quick Ratio too high?
Middle East Pharmaceutical Industries Co's current Quick Ratio of 2.18 is near median its 10-year median of 2.06. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 2.74. The Drug Manufacturers industry median Quick Ratio is 1.45. Middle East Pharmaceutical Industries Co's value of 2.18 is 50.3% above this industry median. Based on the distribution chart, Middle East Pharmaceutical Industries Co ranks #336 out of 997 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Middle East Pharmaceutical Industries Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Middle East Pharmaceutical Industries Co's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Middle East Pharmaceutical Industries Co ranks #336 out of 997 companies for Quick Ratio. This puts Middle East Pharmaceutical Industries Co in the upper half of its industry. The industry median Quick Ratio is 1.45. Middle East Pharmaceutical Industries Co's value of 2.18 is 50.3% above this benchmark. Historically, Middle East Pharmaceutical Industries Co's own Quick Ratio has ranged from 1.43 to 2.74 over the past decade. While the company's 10-year median is 2.06 vs. the industry median of 1.45, Middle East Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Pharmaceutical Industries Co's current Quick Ratio of 2.18 is 50.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Middle East Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Pharmaceutical Industries Co's current Quick Ratio is 2.18, which is near median its own 10-year median of 2.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Pharmaceutical Industries Co stock overvalued right now?
Middle East Pharmaceutical Industries Co (SAU:4016) has a current Quick Ratio of 2.18. The current Quick Ratio is 2.18, which is near median its 10-year median of 2.06 and 50.3% above the Drug Manufacturers industry median of 1.45. Middle East Pharmaceutical Industries Co's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Middle East Pharmaceutical Industries Co (SAU:4016), the current Quick Ratio is 2.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Middle East Pharmaceutical Industries Co Business Description
Middle East Pharmaceutical Industries Co is a holding company engaged in manufacturing medicines, medicated and non-medicated creams and gels. The company operates in Private, Public, and Export segments. Geographically, it generates the majority of its revenue from Saudi Arabia.
22GF Score
Get the complete analysis for SAU:4016
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4016 has been successfully added to your 
